KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Castle Biosciences (CSTL) Shares Issued (2018 - 2025)

Castle Biosciences' Shares Issued history spans 7 years, with the latest figure at $2.1 million for Q4 2025.

  • For Q4 2025, Shares Issued rose 460.86% year-over-year to $2.1 million; the TTM value through Dec 2025 reached $2.2 million, up 9.37%, while the annual FY2025 figure was $2.2 million, 9.37% up from the prior year.
  • Shares Issued for Q4 2025 was $2.1 million at Castle Biosciences, up from -$1.4 million in the prior quarter.
  • Across five years, Shares Issued topped out at $2.5 million in Q4 2023 and bottomed at -$1.5 million in Q3 2023.
  • The 5-year median for Shares Issued is $660000.0 (2022), against an average of $599950.0.
  • The largest annual shift saw Shares Issued skyrocketed 1295.77% in 2021 before it plummeted 595.35% in 2023.
  • A 5-year view of Shares Issued shows it stood at $2.5 million in 2021, then tumbled by 139.62% to -$979000.0 in 2022, then skyrocketed by 356.59% to $2.5 million in 2023, then tumbled by 85.15% to $373000.0 in 2024, then soared by 460.86% to $2.1 million in 2025.
  • Per Business Quant, the three most recent readings for CSTL's Shares Issued are $2.1 million (Q4 2025), -$1.4 million (Q3 2025), and $1.5 million (Q2 2025).